Table 1.
Baseline variables of the study population.
| Patients N=29 |
|
|---|---|
| Age, (years)a | 72.5 (6.8) |
| Male sex | 18 (62.1) |
| Current or former smoke | 13 (44.8) |
| Hypertension | 18 (62.1) |
| Diabetes mellitus | 4 (13.1) |
| Dyslipidemia | 13 (44.8) |
| Cerebrovascular symptoms | 19 (65.5) |
| Chronic kidney disease | 3 (10.3) |
| Coronary artery disease | 11 (37.9) |
| Aspirin treatment | 21 (72.4) |
| Statin treatment | 25 (86.2) |
| CRP, (mg/L)a | 5.3 (8.6) |
| Total cholesterol, (mM/l)a | 5.6 (9.1) |
| LDL cholesterol, (mM/l)a | 2.3 (1.3) |
| HDL cholesterol, (mM/l)a | 2.6 (6.8) |
| Triglycerides, (mM/l)a | 2.7 (7.3) |
| LDL/HDL ratio | 1.8 (1.1) |
| Creatinina | 25 (86.2) |
| eGFR ml/min/1.73 m2 | 73.6 (16.4) |
| HbA1c, (%)a | 6.2 (1.5) |
Data are given as number (percentages) or a mean (SD). HDL, high-density lipoprotein; LDL, low-density lipoprotein; eGFR, estimated Glomerular filtration rate.